![James Caruso](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Caruso
Chief Executive Officer at
CELLECTAR BIOSCIENCES, INC.
Net worth: 36 543 $ as of 31/05/2026
Profile
James V.
Caruso is the founder of Hip Innovation Technology LLC, founded in 2010, where the title held is Director since 2015.
The current job is President, Chief Executive Officer & Director at Cellectar Biosciences, Inc., starting in 2015.
Former jobs include Senior Vice President-Sales & Marketing at Bone Care International, Inc. from 2002 to 2005; Chief Commercial Officer & Executive VP at Allos Therapeutics, Inc. from 2006 to 2010; Vice President-Neuroscience Specialty Sales at Novartis Corp.
from 2001 to 2002; Vice President-Sales at Knoll Pharmaceutical Co. from 2000 to 2001; and Vice President-Primary & Specialty Sales at BASF Pharma Ltd. from 2000 to 2001.
Education includes undergraduate studies at the University of Nevada.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 19/05/2026 | 11,638 ( 0.15% ) | 36 543 $ | 31/05/2026 |
James Caruso active positions
| Companies | Position | Start |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Chief Executive Officer | 15/06/2015 |
Hip Innovation Technology LLC
 Hip Innovation Technology LLC Medical DistributorsDistribution Services Sells hip implant systems and components | Founder | 01/08/2010 |
Former positions of James Caruso
| Companies | Position | End |
|---|---|---|
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Corporate Officer/Principal | 24/08/2010 |
Bone Care International, Inc.
 Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Developed innovative therapeutic and pharmaceutical products | Sales & Marketing | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Sales & Marketing | 01/06/2002 |
BASF Pharma Ltd.
 BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Produces excipients and active ingredients | Sales & Marketing | 01/05/2001 |
Knoll Pharmaceutical Co. | Sales & Marketing | 01/01/2001 |
Training of James Caruso
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
43
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Bone Care International, Inc.
Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Developed innovative therapeutic and pharmaceutical products | Health Technology |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Hip Innovation Technology LLC
Hip Innovation Technology LLC Medical DistributorsDistribution Services Sells hip implant systems and components | Distribution Services |
BASF Pharma Ltd.
BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Produces excipients and active ingredients | Health Technology |
University of Nevada
 University of Nevada Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Knoll Pharmaceutical Co. | |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
- Stock Market
- Insiders
- James Caruso
